Effect of heterozygous PPARgamma deficiency and TZD treatment on insulin resistance associated with age and high-fat feeding

Departments of 1 Surgery and 2 Medicine, University of California, San Diego, 3 San Diego Veterans Affairs Medical Center; 4 Whittier Diabetes Institute; and 5 Gene Expression Laboratory, Howard Hughes Medical Institute, Salk Institute, La Jolla, California 92093 Peroxisome proliferator-activat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of physiology: endocrinology and metabolism 2003-03, Vol.284 (3), p.E618-E626
Hauptverfasser:	Miles, Philip D. G, Barak, Yaacov, Evans, Ronald M, Olefsky, Jerrold M
Format:	Artikel
Sprache:	eng
Schlagworte:	Aging - physiology Animals Chromans - therapeutic use Dietary Fats - administration & dosage Heterozygote Insulin Resistance Metabolism, Inborn Errors - drug therapy Metabolism, Inborn Errors - genetics Metabolism, Inborn Errors - physiopathology Mice Mice, Inbred C57BL Mice, Knockout - genetics Receptors, Cytoplasmic and Nuclear - deficiency Receptors, Cytoplasmic and Nuclear - genetics Thiazoles - therapeutic use Thiazolidinediones Transcription Factors - deficiency Transcription Factors - genetics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!